0.94% -0.0266

Dna X Inc (SONM)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Dna X Inc Stock (SONM) Company Profile

Technology (775)

650-378-8100

4445 EASTGATE MALL, SAN DIEGO, TX

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SONM's Discussions on Twitter

Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SONM Dna X Inc	5.30	7.90M	57.92M	-31.14M	-19.56M	-5.5628
MSFT Microsoft Corporation	405.24	3.00T	305.45B	119.26B	77.41B	15.98
ORCL Oracle Corp	151.29	428.27B	61.02B	15.61B	-13.18B	5.3211
PLTR Palantir Technologies Inc	151.45	352.10B	4.48B	1.63B	2.10B	0.6328
CRWD Crowdstrike Holdings Inc	387.81	98.68B	4.57B	-315.36M	1.10B	-1.2634
SNPS Synopsys Inc	425.16	81.28B	8.00B	1.10B	2.28B	6.4708

Dna X Inc Stock (SONM) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2019-10-31	Herabstufung	Oppenheimer	Outperform → Perform
2019-07-18	Eingeleitet	B. Riley FBR	Buy
2019-07-09	Hochstufung	National Securities	Neutral → Buy
2019-06-10	Eingeleitet	National Securities	Neutral
2019-06-04	Eingeleitet	Lake Street	Buy
2019-06-04	Eingeleitet	Oppenheimer	Outperform

Alle ansehen

Dna X Inc Aktie (SONM) Neueste Nachrichten

Finanzdaten der Dna X Inc-Aktie (SONM)

Dna X Inc-Aktie (SONM) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
LYTTON LAURENCE W	10% Owner	Jun 30 '25	Sale	1.39	400,514	556,714	0
Becher Charles	See Remarks	Apr 23 '25	Sale	1.45	31,326	45,423	62,668
MULICA MICHAEL C	Director	Apr 23 '25	Sale	1.45	27,818	40,336	73,292
Crolius Clayton	Chief Financial Officer	Apr 23 '25	Sale	1.45	11,634	16,869	30,958
Cassano James S	Director	Apr 23 '25	Sale	1.45	23,381	33,902	49,126
Wang Jeffrey	Director	Apr 23 '25	Sale	1.45	4,478	6,493	21,301
Steenstra Jack	Director	Apr 23 '25	Sale	1.45	23,381	33,902	49,139

Dna X Inc (SONM)

Dna X Inc Stock (SONM) Company Profile

Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS

Dna X Inc Stock (SONM) Upgrades & Downgrades

Dna X Inc Aktie (SONM) Neueste Nachrichten

SONM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

DNA X (NASDAQ: SONM) revises view of DNA X LLC acquisition - Stock Titan

DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

How DNA's Double Helix Structure Was Discovered - Britannica

SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan

Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors - Yahoo Finance Singapore

Major SONM holder DNA Holdings Venture reports 223,201 shares - Stock Titan

Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation - Stock Titan

1 Main Capital exits Sonim Technologies (SONM) with 0.0% ownership - Stock Titan

Leadership and Strategy Shift at DNA X Following Core Business Divestment - AD HOC NEWS

Sonim Technologies Names Mike Mulica Acting Chief Executive - TipRanks

DNA X, Inc. Appoints Mike Mulica as Acting Chief Executive Officer, Effective February 9, 2026 - marketscreener.com

DNAX stock jumps to $0.0001 on 09 Feb 2026 (PNK): liquidity and valuation in focus - Meyka

Nancy Guthrie’s blood was found on her porch, DNA testing confirms - WBAY

Sonim Technologies Sees Executive Departures and New Board Appointment - TipRanks

Leadership shake-up at DNA X (NASDAQ: SONM) as CEO exits and investor designee joins board - Stock Titan

Acurx patent backs new antibiotics for C. diff and MRSA - Stock Titan

Will Sonim Technologies Inc. stock outperform value stocksJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - mfd.ru

Best Tech Penny Stocks Right Now • Updated Daily - Benzinga

Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - IT Business Net

Five reasons to go rugged in public safety: Sonim Technologies on building phones for fireground realties - International Fire & Safety Journal

Sonim Technologies rebrands as DNA X following asset sale to NEXA - Investing.com Nigeria

Sonim Technologies Rebrands as DNA X, Shifts Strategy - TipRanks

DNA X Signs Asset Purchase Agreement Amendment and Terminates Streeterville Notes - TradingView

Sonim sells assets, rebrands as DNA X running digital asset platform - stocktitan.net

EPS Watch: Is Sonim Technologies Inc exposed to currency risksMarket Trend Review & Entry Point Confirmation Signals - baoquankhu1.vn

Market Wrap: Is Sonim Technologies Inc affected by consumer sentimentWeekly Stock Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn

Sonim Technologies : NEXA Completes Acquisition of Sonim - marketscreener.com

Sonim Technologies : News Release - marketscreener.com

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Drops Despite Market Gains: Important Facts to Note - Nasdaq

Sonim Technologies (SONM) Projected to Post Earnings on Friday - Defense World

Volatility Watch: Should value investors consider Sonim Technologies IncWeekly Trade Report & Risk Managed Investment Entry Signals - baoquankhu1.vn

Sentiment Review: What is the Moat Score of Sonim Technologies IncJuly 2025 Snapshot & Weekly Setup with High ROI Potential - baoquankhu1.vn

Portfolio Recap: What are the risks of holding Sonim Technologies IncJuly 2025 Trade Ideas & Reliable Breakout Stock Forecasts - baoquankhu1.vn

Whats the fair value of Sonim Technologies Inc stockTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Resistance Check: Will Sonim Technologies Inc benefit from seasonalityWeekly Trade Summary & Weekly Chart Analysis and Guides - baoquankhu1.vn

Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products - Business Wire

Quarterly Trades: Is Sonim Technologies Inc affected by consumer sentimentWeekly Trend Recap & Weekly Consistent Profit Watchlists - baoquankhu1.vn

Inflation Data: Can Sonim Technologies Inc stock hit analyst price targets2025 Key Highlights & Reliable Intraday Trade Plans - Bộ Nội Vụ

Options Flow: Will Sonim Technologies Inc stock outperform tech sector in 2025Stop Loss & Low Risk Growth Stock Ideas - Bộ Nội Vụ

Inflation Data: Will Sonim Technologies Inc. stock outperform tech sector in 2025Treasury Yields & Daily Entry Point Trade Alerts - Bộ Nội Vụ

VIX Spike: Why Sonim Technologies Inc. stock is favored by top institutionsProfit Target & Daily Volume Surge Trade Alerts - Bộ Nội Vụ

Is Sonim Technologies Inc. (6RO) stock overpriced at current multiplesChart Signals & Low Drawdown Trading Strategies - ulpravda.ru

Loss Report: How Sonim Technologies Inc stock performs in weak economyWeekly Stock Recap & Daily Entry Point Trade Alerts - Bộ Nội Vụ

Will Sonim Technologies Inc. (2W9) stock boost dividends further2025 Investor Takeaways & High Yield Stock Recommendations - Улправда

Can Sonim Technologies Inc. stock maintain growth trajectoryEarnings Overview Summary & Accurate Buy Signal Alerts - Улправда

Market Recap: How rising interest rates impact Sonim Technologies Inc. stock2025 Market WrapUp & AI Powered Buy and Sell Recommendations - Улправда

How rising interest rates impact Sonim Technologies Inc. stockQuarterly Portfolio Summary & Precise Trade Entry Recommendations - Улправда

How Sonim Technologies Inc. stock valuations compare to rivalsMomentum Trading Signals & Market Trend Real-Time Reports - ulpravda.ru

The Truth About Myriad Genetics Inc: Is This DNA Stock a Sleeper Goldmine or Just Overhyped? - AD HOC NEWS

Sonim stockholders approve sale of rugged device business to NEXA By Investing.com - Investing.com Australia

Finanzdaten der Dna X Inc-Aktie (SONM)

Umsatz

Nettogewinn

Free Cashflow

ENV

Dna X Inc-Aktie (SONM) Insiderhandel

Ähnlich wie SONM